Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine Dr. Kamal Kant Kohli13 July 2022 8:30 PM ISTPeople with hematologic malignancies-or blood cancers including leukemia, lymphoma, and multiple myeloma-have an impaired immune system due to their...
A machine learning model to predict immunotherapy response in cancer patients Isra Zaman12 July 2022 9:45 AM ISTThe recently developed immune checkpoint inhibitor has considerably improved the survival rate of patients with cancer. However, the problem with...
Preoperative MRI may lead to better surgical outcomes for prostate cancer patients Dr. Kamal Kant Kohli28 Jun 2022 7:30 PM ISTImaging techniques are important tools in cancer diagnosis and treatment, but their use remains limited in prostate cancer patients. Systematic...
New blood test may identify which colon cancer patients need chemotherapy Dr. Kamal Kant Kohli28 Jun 2022 5:30 AM ISTAustralian-US researchers have developed a new blood test that could revolutionise how chemotherapy is used for colon cancer, by identifying the...
Mushroom extract may help in clearance of HPV infections Dr. Kamal Kant Kohli27 Jun 2022 8:00 PM ISTDaily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth...
MRI guided high-intensity focused ultrasound can control prostate cancer with fewer side effects: Lancet Dr. Kamal Kant Kohli26 Jun 2022 8:00 PM ISTIn recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be...
Everolimus after surgery can improve outcomes in those with high-risk kidney cancer Dr. Kamal Kant Kohli16 Jun 2022 7:30 PM ISTIn a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to one year after surgery lived longer...
Radiotherapy not always needed for elderly women with low-risk luminal A breast cancer Dr. Kamal Kant Kohli12 Jun 2022 8:00 PM ISTElderly women with low-risk luminal A breast cancer can safely avoid radiotherapy with guidance from Ki67 proliferation marker screening, finds phase...
Ibrutinib with Chemoimmunotherapy Improved Progression-Free Survival of Newly Diagnosed Mantle Cell Lymphoma Patients Dr. Kamal Kant Kohli10 Jun 2022 7:15 PM ISTCombination chemoimmunotherapy with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over...
Counting cancerous lymph nodes best predictor of mortality across most cancers Dr. Kamal Kant Kohli7 Jun 2022 7:15 PM ISTDetermining a cancer patient's prognosis-the likely course and outcome of their disease-typically involves staging the lymph nodes, a process that...
Cancer increases risk of developing diabetes, finds study Dr. Kamal Kant Kohli6 Jun 2022 9:15 AM ISTCancer is the leading cause of death in Denmark, which has a population of close to 6 million people. In 2019 alone, more than 45,000 incident cases...
New drug combination improves survival for some with lung cancer Dr. Kamal Kant Kohli4 Jun 2022 6:45 AM ISTPatients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when subsequently...
